USA researchers identify potential biomarkers for detection and treatment of triple-negative breast cancer

“The broader vision and mission of our study is to develop a minimally invasive blood test kit for early diagnostics, monitoring, and guiding therapeutic planning of triple-negative breast cancer patients.”

IJMS, Free Full-Text

Biomedicines, Free Full-Text

Frontiers Gene expression profile analysis to discover molecular

Seema Singh, Ph.D.

Ajay P. Singh, Ph.D.

The role of autoantibodies biomarkers in precision medicine

Seema Singh, Ph.D.

Identification and validation of plasma biomarkers for diagnosis

Frontiers Immune Checkpoint Inhibitors in Triple Negative Breast

Large Studies Evaluating How to Personalize Breast Cancer

Breast Cancer Research Foundation of Alabama on LinkedIn: #breastcancerawarenessmonth

Current advances in prognostic and diagnostic biomarkers for solid

Triple negative breast cancer: A thorough review of biomarkers

New Biomarker Classifications May Improve Treatment for High-Risk

Hypoxia imaging and combination therapy aid immunotherapy